Page last updated: 2024-08-22

trimetazidine and Hypertrophy, Right Ventricular

trimetazidine has been researched along with Hypertrophy, Right Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, SL; Bache-Wiig, P; Fang, YH; Hong, Z; Marsboom, G; Piao, L; Rehman, J; Toth, PT1
Guarnieri, C; Muscari, C1

Other Studies

2 other study(ies) available for trimetazidine and Hypertrophy, Right Ventricular

ArticleYear
Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
    Journal of molecular medicine (Berlin, Germany), 2012, Volume: 90, Issue:1

    Topics: Acetanilides; Animals; Enzyme Inhibitors; Fatty Acids; Glucose Transporter Type 1; Glycogen; Glycolysis; Hexokinase; Hypertrophy, Right Ventricular; Male; Myocytes, Cardiac; Oxidation-Reduction; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents; Ventricular Function, Right

2012
Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium.
    Pharmacology, 1993, Volume: 46, Issue:6

    Topics: Animals; Hypertrophy, Right Ventricular; Male; Mitochondria, Heart; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Trimetazidine

1993